A detailed history of Sg Americas Securities, LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 38,704 shares of ARDX stock, worth $192,358. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,704
Previous 91,672 57.78%
Holding current value
$192,358
Previous $679,000 60.68%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

SELL
$5.28 - $7.57 $279,671 - $400,967
-52,968 Reduced 57.78%
38,704 $267,000
Q2 2024

Jul 12, 2024

BUY
$5.89 - $9.31 $399,047 - $630,752
67,750 Added 283.21%
91,672 $679,000
Q1 2024

May 06, 2024

SELL
$6.05 - $9.74 $485,778 - $782,063
-80,294 Reduced 77.05%
23,922 $175,000
Q4 2023

Jan 12, 2024

SELL
$3.29 - $6.64 $341,291 - $688,807
-103,736 Reduced 49.88%
104,216 $646,000
Q3 2023

Oct 13, 2023

BUY
$3.3 - $4.83 $686,241 - $1 Million
207,952 New
207,952 $848,000
Q1 2022

Apr 29, 2022

SELL
$0.65 - $1.18 $14,384 - $26,113
-22,130 Closed
0 $0
Q4 2021

Feb 07, 2022

SELL
$0.86 - $1.7 $22,708 - $44,888
-26,405 Reduced 54.4%
22,130 $24,000
Q3 2021

Nov 01, 2021

BUY
$1.27 - $8.17 $61,639 - $396,530
48,535 New
48,535 $64,000
Q2 2021

Aug 12, 2021

SELL
$6.55 - $8.98 $104,217 - $142,880
-15,911 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$6.1 - $7.69 $30,414 - $38,342
4,986 Added 45.64%
15,911 $105,000
Q4 2020

Feb 04, 2021

BUY
$5.05 - $7.1 $55,171 - $77,567
10,925 New
10,925 $71,000
Q3 2020

Nov 09, 2020

SELL
$5.25 - $7.08 $97,707 - $131,765
-18,611 Closed
0 $0
Q2 2020

Jul 20, 2020

SELL
$5.37 - $8.11 $29,438 - $44,459
-5,482 Reduced 22.75%
18,611 $129,000
Q1 2020

Apr 30, 2020

BUY
$4.35 - $8.79 $48,789 - $98,588
11,216 Added 87.1%
24,093 $137,000
Q4 2019

Jan 28, 2020

BUY
$4.23 - $8.29 $54,469 - $106,750
12,877 New
12,877 $97,000
Q3 2019

Nov 04, 2019

SELL
$2.15 - $6.28 $55,491 - $162,086
-25,810 Closed
0 $0
Q2 2019

Jul 29, 2019

BUY
$2.49 - $3.73 $64,266 - $96,271
25,810 New
25,810 $69,000
Q1 2019

Apr 29, 2019

SELL
$1.88 - $3.35 $51,869 - $92,426
-27,590 Closed
0 $0
Q4 2018

Feb 01, 2019

BUY
$1.66 - $4.16 $45,799 - $114,774
27,590 New
27,590 $49,000
Q4 2017

Jan 24, 2018

SELL
$4.85 - $7.8 $77,905 - $125,291
-16,063 Closed
0 $0
Q3 2017

Nov 07, 2017

BUY
$4.35 - $5.7 $69,874 - $91,559
16,063
16,063 $90,000

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $769M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.